ImageneBio annual current ratio
2020
2021
2022
2023
2024
2025
ImageneBio Current Ratio Growth & History (IMA)
ImageneBio's current ratio was 12.49 for fiscal 2025.
View full ImageneBio company overviewImageneBio annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 12.49 | 11.76 | +1623.63% |
| 2024 | 2024-12-31 | 0.72 | −11.85 | −94.24% |
| 2023 | 2023-12-31 | 12.58 | 5.14 | +69.02% |
| 2022 | 2022-12-31 | 7.44 | −1.26 | −14.46% |
| 2021 | 2021-12-31 | 8.70 | 2.84 | +48.50% |
| 2020 | 2020-12-31 | 5.86 | — | — |
ImageneBio quarterly current ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 21.47 | 7.95 | +58.80% |
| Q1 2026 | 2026-03-31 | 18.39 | 5.09 | +38.22% |
| Q4 2025 | 2025-12-31 | 12.49 | 11.76 | +1623.63% |
| Q3 2025 | 2025-09-30 | 13.24 | −2.08 | −13.57% |
| Q2 2025 | 2025-06-30 | 13.52 | −4.70 | −25.80% |
| Q1 2025 | 2025-03-31 | 13.31 | −2.54 | −16.04% |
| Q4 2024 | 2024-12-31 | 0.72 | −11.85 | −94.24% |
| Q3 2024 | 2024-09-30 | 15.32 | 4.91 | +47.12% |
| Q2 2024 | 2024-06-30 | 18.22 | 4.84 | +36.18% |
| Q1 2024 | 2024-03-31 | 15.85 | 5.73 | +56.60% |
| Q4 2023 | 2023-12-31 | 12.58 | 5.14 | +69.02% |
| Q3 2023 | 2023-09-30 | 10.41 | 3.30 | +46.48% |
| Q2 2023 | 2023-06-30 | 13.38 | 6.39 | +91.55% |
| Q1 2023 | 2023-03-31 | 10.12 | 1.59 | +18.66% |
| Q4 2022 | 2022-12-31 | 7.44 | −1.26 | −14.46% |
| Q3 2022 | 2022-09-30 | 7.11 | −1.13 | −13.72% |
| Q2 2022 | 2022-06-30 | 6.98 | −1.81 | −20.61% |
| Q1 2022 | 2022-03-31 | 8.53 | −0.91 | −9.62% |
| Q4 2021 | 2021-12-31 | 8.70 | 2.84 | +48.50% |
| Q3 2021 | 2021-09-30 | 8.24 | — | — |
| Q2 2021 | 2021-06-30 | 8.80 | — | — |
| Q1 2021 | 2021-03-31 | 9.44 | — | — |
| Q4 2020 | 2020-12-31 | 5.86 | — | — |
ImageneBio current ratio trends
Over the last five fiscal years, ImageneBio's current ratio increased from 5.86 to 12.49, a change of 6.63. The latest reported quarter, Q2 2026, shows 21.47.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ImageneBio source filings ↗